US Broker Ratings

McKesson Corporation (MCK) Investor Outlook: Analyzing a Potential 11.26% Upside in the Healthcare Giant

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, continues to capture investor interest with its robust market presence and promising growth potential. With a..

Amgen Inc. (AMGN) Stock Analysis: Navigating Market Dynamics with a Strong 91.47% Return on Equity

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, particularly in the drug manufacturing industry, continues to capture investor attention with its robust financial performance..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Strong Buy Ratings and Promising Growth in Healthcare

Thermo Fisher Scientific Inc (NYSE: TMO), a stalwart in the healthcare sector, continues to capture investor attention with its robust market presence and promising growth metrics...

Johnson & Johnson (JNJ) Stock Analysis: Strong Investor Confidence with 16 Buy Ratings and a 4.64% Potential Upside

Johnson & Johnson, trading under the ticker symbol JNJ, stands as a formidable entity in the healthcare sector, boasting a market capitalization of $640.02 billion. This..

Alkermes plc (ALKS) Investor Outlook: Strong Buy Ratings and 21% Potential Upside

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector, is drawing significant attention from investors due to its robust performance metrics and growth potential...

Bausch + Lomb Corporation (BLCO) Investor Outlook: Eyeing a 3.24% Upside Amid Diverse Global Operations

Bausch + Lomb Corporation (NYSE: BLCO), a venerable player in the healthcare sector, is renowned for its comprehensive suite of eye health products and services. With..

Waystar Holding Corp. (WAY) Stock Analysis: A Promising 32.85% Upside in Healthcare Information Services

Waystar Holding Corp. (NASDAQ: WAY) is making waves in the healthcare information services sector with its innovative cloud-based software solutions aimed at streamlining healthcare payments. With..

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring an 18% Potential Upside in the Healthcare Sector

Option Care Health, Inc. (NASDAQ: OPCH) stands out as a noteworthy player in the healthcare sector, specifically within the medical care facilities industry. With a market..

Glaukos Corporation (GKOS)

⚠️ No article content returned.

..

Atrium Therapeutics, Inc. (RNA): Analyst Consensus Highlights 76% Potential Upside for Biotechnology Innovator

Atrium Therapeutics, Inc. (NASDAQ: RNA) is capturing investor attention with its promising potential in the biotechnology sector. Specializing in RNA therapeutics aimed at treating cardiomyopathies, the..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating Current Market Challenges with Strategic Insights

Bio-Rad Laboratories, Inc. (NYSE: BIO), a key player in the healthcare sector, specifically in the medical devices industry, is currently under the investor spotlight as it..

Sarepta Therapeutics (SRPT) Stock Analysis: Navigating the Biotech Landscape with Innovative Therapies

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a key player in the biotechnology sector, offers a compelling story for investors interested in healthcare innovations, particularly in the realm..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating Volatility with a 21.6% Revenue Growth

Tempus AI, Inc. (NASDAQ: TEM), a formidable player in the healthcare technology sector, is generating significant interest among investors despite its volatile stock performance. With a..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: A 36.45% Potential Upside in the Biotech Arena

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands as a compelling candidate for investors eyeing the biotechnology sector, with its focus on rare neuroendocrine diseases. The company, headquartered..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: A Promising 80% Upside Potential for Investors

Telix Pharmaceuticals Limited (ASX: TLX) has emerged as a compelling opportunity for investors in the biotechnology sector, primarily due to its substantial growth potential and cutting-edge..

Legend Biotech Corporation (LEGN): Investor Outlook on a Biotech Powerhouse with a 128.84% Upside Potential

Legend Biotech Corporation (NASDAQ: LEGN) is making waves in the biotechnology sector, with a compelling narrative that positions it as a formidable player in the cell..

Axsome Therapeutics (AXSM) Investor Outlook: Unveiling a 38% Upside Potential Amidst Rapid Growth in CNS Therapies

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a pioneering biopharmaceutical company, continues to capture the attention of investors with its robust growth trajectory in the healthcare sector, specifically..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Unveiling a 7.47% Potential Upside with Promising Genetic Medicine Innovations

Krystal Biotech, Inc. (NASDAQ: KRYS) has emerged as a formidable player in the biotechnology sector, focusing on the development and commercialization of genetic medicines aimed at..

RadNet, Inc. (RDNT) Stock Analysis: Exploring a Potential 28.37% Upside with Strong Buy Ratings

For investors seeking opportunities in the healthcare sector, RadNet, Inc. (NASDAQ: RDNT) presents an intriguing proposition. With a market capitalization of $5.8 billion, RadNet is a..

Nuvalent, Inc. (NUVL) Stock Analysis: What Investors Need to Know About This $9.81 Billion Biotech Player

Nuvalent, Inc. (NASDAQ: NUVL) is carving out its niche in the competitive biotechnology sector with a strong focus on developing innovative cancer therapies. With a market..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds